Environmental, Social And Corporate Governance (ESG) Report

Overview

The report describes Yifan Pharmaceutical's first ESG report for 2024, including a 16-issue materiality assessment covering environmental, social and governance topics. It highlights green packaging, including 17.9 tons of renewable materials representing 77.2% of biologics packaging materials. The company reports 4,098 employees and 967 training projects totaling 55,315.5 training hours. It also presents governance oversight by the Board of Directors, broad pharmaceutical innovation activity and an independent limited-assurance engagement over selected key data.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services